Across TCGA pan-cancer cohorts, XKRYP5 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated XKRYP5 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher XKRYP5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated XKRYP5 expression acts as an unfavorable survival marker.

STAD are the cancer types where XKRYP5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.240	0.658	.010	36	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: XKRYP5 tumor-vs-normal RNA expression · all XKRYP5 data types